Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

13.92
+1.037.99%
Post-market: 13.60-0.3200-2.30%17:27 EDT
Volume:86.29K
Turnover:1.19M
Market Cap:201.50M
PE:0.12
High:13.96
Open:13.11
Low:13.11
Close:12.89
Loading ...
May 28, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 15, 2024

Correspondence

Form CORRESP - Correspondence
Jun 11, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership